Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Uterine Cervical Neoplasms"" wg kryterium: Temat


Tytuł :
Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
Autorzy :
Kann H; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Hortlund M; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Eklund C; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Dillner J; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Faust H; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 May 01; Vol. 146 (9), pp. 2539-2546. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cervical Intraepithelial Neoplasia/*virology
DNA, Viral/*analysis
Early Detection of Cancer/*methods
Papillomaviridae/*classification
Papillomavirus Infections/*complications
Papillomavirus Vaccines/*administration & dosage
Uterine Cervical Neoplasms/*virology
Adolescent ; Adult ; Case-Control Studies ; Cervical Intraepithelial Neoplasia/epidemiology ; Cervical Intraepithelial Neoplasia/pathology ; DNA, Viral/genetics ; Female ; Follow-Up Studies ; Humans ; Papillomaviridae/genetics ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/prevention & control ; Papillomavirus Infections/virology ; Prognosis ; Sweden/epidemiology ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/pathology ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Effects of exposure to polycyclic aromatic hydrocarbons combined with high-risk human papillomavirus infection on cervical intraepithelial neoplasia: A population study in Shanxi Province, China.
Autorzy :
Li X; Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, China.
Ding L; Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, China.
Song L; Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, China.
Gao W; Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, China.
Wang L; Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, China.
Wang J; Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 May 01; Vol. 146 (9), pp. 2406-2412. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Squamous Cell/*epidemiology
Cervical Intraepithelial Neoplasia/*epidemiology
Papillomaviridae/*pathogenicity
Papillomavirus Infections/*complications
Pyrenes/*adverse effects
Uterine Cervical Neoplasms/*epidemiology
Adolescent ; Adult ; Aged ; Carcinoma, Squamous Cell/etiology ; Carcinoma, Squamous Cell/pathology ; Cervical Intraepithelial Neoplasia/etiology ; Cervical Intraepithelial Neoplasia/pathology ; China/epidemiology ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Incidence ; Middle Aged ; Papillomavirus Infections/virology ; Prognosis ; Risk Factors ; Uterine Cervical Neoplasms/etiology ; Uterine Cervical Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.
Autorzy :
Stoler MH; Department of Pathology, University of Virginia Health System, Charlottesville, VA.
Baker E; Roche Molecular Systems Inc., Pleasanton, CA.
Boyle S; Roche Molecular Systems Inc., Pleasanton, CA.
Aslam S; Roche Molecular Systems Inc., Pleasanton, CA.
Ridder R; Ventana Medical Systems, Inc. (Roche Tissue Diagnostics), Tucson, AZ.
Huh WK; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL.
Wright TC Jr; Department of Pathology, Columbia University, New York City, NY.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 May 01; Vol. 146 (9), pp. 2599-2607. Date of Electronic Publication: 2019 Oct 06.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cyclin-Dependent Kinase Inhibitor p16/*metabolism
Ki-67 Antigen/*metabolism
Mass Screening/*standards
Papillomaviridae/*genetics
Papillomavirus Infections/*diagnosis
Triage/*standards
Uterine Cervical Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Cervical Intraepithelial Neoplasia/diagnosis ; Cervical Intraepithelial Neoplasia/epidemiology ; Cervical Intraepithelial Neoplasia/virology ; Cytodiagnosis ; DNA, Viral/analysis ; Female ; Follow-Up Studies ; Genotype ; Humans ; Middle Aged ; Papillomaviridae/classification ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/complications ; Papillomavirus Infections/virology ; Prognosis ; Retrospective Studies ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/virology ; Young Adult
Czasopismo naukowe
Tytuł :
Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer.
Autorzy :
Cosper PF; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
McNair C; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
González I; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Wong N; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.; Department of Biomedical Engineering, School of Engineering & Applied Science, Washington University, St. Louis, MO.
Knudsen KE; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Chen JJ; Department of Microbiology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong, China.
Markovina S; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Schwarz JK; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Grigsby PW; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Wang X; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO.; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 2047-2058. Date of Electronic Publication: 2019 Dec 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm*/immunology
Gene Expression Regulation, Viral*
Immunomodulation/*drug effects
Papillomaviridae/*genetics
Papillomavirus Infections/*complications
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*etiology
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biopsy ; Combined Modality Therapy ; Female ; Gene Expression Profiling ; Humans ; Lymphatic Metastasis ; Neoplasm Staging ; Papillomaviridae/classification ; Papillomaviridae/immunology ; Papillomavirus Infections/immunology ; Prognosis ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/mortality
Czasopismo naukowe
Tytuł :
Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.
Autorzy :
Coldman AJ; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
van Niekerk D; Cervical Cancer Screening Program, BC Cancer, Vancouver, BC, Canada.
Krajden M; BC Centre for Disease Control, Vancouver, BC, Canada.
Smith LW; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
Cook D; BC Centre for Disease Control, Vancouver, BC, Canada.
Gondara L; Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
Ceballos K; Cervical Cancer Screening Program, BC Cancer, Vancouver, BC, Canada.
Quinlan DJ; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
Lee M; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
Elwood-Martin R; School of Public Health, University of British Columbia, Vancouver, BC, Canada.
Gentile L; Cervical Cancer Screening Program, BC Cancer, Vancouver, BC, Canada.
Peacock S; Canadian Centre for Applied Research in Cancer Control, BC Cancer, Vancouver, BC, Canada.
Stuart GCE; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, Canada.
Franco EL; Division of Cancer Epidemiology, McGill University, Montreal, QC, Canada.
Ogilvie GS; Women's Health Research Institute, Vancouver, BC, Canada.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 1810-1818. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Papillomaviridae*
Papillomavirus Infections/*complications
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*epidemiology
Uterine Cervical Neoplasms/*etiology
Adult ; Aged ; British Columbia/epidemiology ; Cervical Intraepithelial Neoplasia/epidemiology ; Cervical Intraepithelial Neoplasia/etiology ; DNA, Viral ; Female ; Humans ; Mass Screening ; Middle Aged ; Papillomavirus Infections/diagnosis ; Public Health Surveillance ; Uterine Cervical Neoplasms/diagnosis
Czasopismo naukowe
Tytuł :
Highly immunosuppressive HLADR regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma.
Autorzy :
Yang H; Department of Gynecological Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Ye S; Department of Gynecological Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Goswami S; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Li T; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Wu J; Department of Gynecological Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Cao C; Cancer Institute, Fudan University, Shanghai Cancer Center, Shanghai, China.
Ma J; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Lu B; Rudong People's Hospital, Jiangsu, China.
Pei X; Department of Gynecological Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen Y; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Yu J; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Xu H; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Qiu L; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Afridi S; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.; Department of Biological Sciences (DBS), National University of Medical Sciences (NUMS), Secretariat c/o Military Hospital, Adjacent to Armed Force Institute of Cardiology, Rawalpindi, Pakistan.
Xiang L; Department of Gynecological Oncology, Shanghai Cancer Center, Fudan University, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang X; The Center for Microbes, Development and Health, Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Apr 01; Vol. 146 (7), pp. 1993-2006. Date of Electronic Publication: 2019 Nov 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunomodulation*
HLA-DR Antigens/*metabolism
Lymphocytes, Tumor-Infiltrating/*immunology
Lymphocytes, Tumor-Infiltrating/*metabolism
T-Lymphocytes, Regulatory/*immunology
T-Lymphocytes, Regulatory/*metabolism
Uterine Cervical Neoplasms/*etiology
Uterine Cervical Neoplasms/*metabolism
Apoptosis ; Biomarkers ; Disease Progression ; Female ; HLA-DR Antigens/immunology ; Humans ; Immunohistochemistry ; Lymphocyte Activation ; Lymphocyte Count ; Lymphocytes, Tumor-Infiltrating/pathology ; Phenotype ; Prognosis ; Tumor Microenvironment/immunology ; Uterine Cervical Neoplasms/mortality
Czasopismo naukowe
Tytuł :
Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
Autorzy :
Tawe L; Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.
MacDuffie E; Warren Alpert Medical School of Brown University, Providence, RI.
Narasimhamurthy M; Department of Pathology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Wang Q; Sue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA.
Gaseitsiwe S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.
Moyo S; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA.
Kasvosve I; Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.
Shin SS; Sue & Bill Gross School of Nursing, University of California Irvine, Irvine, CA.
Zetola NM; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Paganotti GM; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Department of Biomedical Sciences, Faculty of Medicine, University of Botswana, Gaborone, Botswana.; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Grover S; Botswana-University of Pennsylvania Partnership, Gaborone, Botswana.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Mar 15; Vol. 146 (6), pp. 1667-1673. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Infections/*virology
Human papillomavirus 16/*isolation & purification
Human papillomavirus 18/*isolation & purification
Papillomavirus Infections/*virology
Uterine Cervical Neoplasms/*virology
Anti-HIV Agents/therapeutic use ; Botswana/epidemiology ; Cervix Uteri/pathology ; Cervix Uteri/virology ; Cost of Illness ; Cross-Sectional Studies ; DNA, Viral/genetics ; DNA, Viral/isolation & purification ; Female ; Genotype ; HIV Infections/complications ; HIV Infections/drug therapy ; Human papillomavirus 16/genetics ; Human papillomavirus 18/genetics ; Humans ; Middle Aged ; Papillomavirus Infections/complications ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/prevention & control ; Papillomavirus Vaccines/administration & dosage ; Prevalence ; Retrospective Studies ; Uterine Cervical Neoplasms/complications ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/prevention & control ; Vaccination
Czasopismo naukowe
Tytuł :
Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
Autorzy :
Wang J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Elfström KM; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Regional Cancer Center of Stockholm Gotland, Stockholm, Sweden.
Andrae B; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Centre for Research and Development, Uppsala University/Region of Gävleborg, Gävle, Sweden.
Nordqvist Kleppe S; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Ploner A; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Lei J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Dillner J; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Sundström K; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Sparén P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Mar 01; Vol. 146 (5), pp. 1230-1240. Date of Electronic Publication: 2019 Jun 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Early Detection of Cancer/*statistics & numerical data
Mass Screening/*organization & administration
Medical Audit/*statistics & numerical data
Patient Participation/*statistics & numerical data
Uterine Cervical Neoplasms/*epidemiology
Adult ; Aged ; Benchmarking/statistics & numerical data ; Case-Control Studies ; Cervix Uteri/pathology ; Female ; Humans ; Mass Screening/statistics & numerical data ; Middle Aged ; Papanicolaou Test/statistics & numerical data ; Pregnancy ; Program Evaluation ; Registries/statistics & numerical data ; Risk Assessment ; Sweden/epidemiology ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Cervical cancer risk in women living with HIV across four continents: A multicohort study.
Autorzy :
Rohner E; Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Bütikofer L; CTU Bern, University of Bern, Switzerland.
Schmidlin K; Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Sengayi M; National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Maskew M; Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Giddy J; Department of Medicine, McCord Hospital, Durban, South Africa.
Taghavi K; Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Moore RD; Johns Hopkins University, School of Medicine, Baltimore, Maryland.
Goedert JJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Gill MJ; University of Calgary, Alberta, Canada.
Silverberg MJ; Division of Research, Kaiser Permanente Northern California, Oakland, USA.
D'Souza G; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Patel P; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia.
Castilho JL; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, USA.
Ross J; TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Sohn A; TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
Bani-Sadr F; Reims Champagne-Ardenne University, Faculté de médecine, CHU Reims, Hôpital Robert Debré, Tropical and Infectious Diseases, Reims, France.
Taylor N; IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumathology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.
Paparizos V; AIDS Unit, Clinic of Venereologic and Dermatologic Diseases, Athens Medical School, 'Syngros' Hospital, Athens, Greece.
Bonnet F; CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, Bordeaux, France.; Univ. Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000 Bordeaux, France.
Verbon A; Department Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Vehreschild JJ; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; German Centre for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
Post FA; King's College Hospital NHS Foundation Trust, London, UK.
Sabin C; Institute for Global Health, UCL, London, United Kingdom.
Mocroft A; Institute for Global Health, UCL, London, United Kingdom.
Dronda F; Department of Infectious Diseases, Hospital Ramón y Cajal, Madrid, Spain.
Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
Grabar S; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013, Paris, France.; INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, F-75013, Paris, France.; Université Paris Descartes et Assistance Publique-Hôpitaux de Paris, Groupe hospitalier Cochin Hôtel-Dieu, Paris, France.
Spagnuolo V; Vita-Salute San Raffaele University, Faculty of Medicine and Surgery, Milan, Italy.
Quiros-Roldan E; Infectious and Tropical Diseases Institute, University of Brescia, Brescia, Italy.
Mussini C; Infectious Diseases Clinics, University Hospital, Modena, Italy.
Miro JM; Infectious Diseases Service, Hospital Clinic - IDIBAPS, University of Barcelona, Barcelona, Spain.
Meyer L; INSERM, U1018, Epidemiology of HIV, Reproduction, Paediatrics, CESP, University Paris-Sud, Paris, France.; Department of Public Health and Epidemiology, Bicêtre Hospital, AP-HP, Le Kremlin Bicêtre, Paris, France.
Hasse B; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland.
Konopnicki D; Department of Infectious Diseases, St Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Roca B; Hospital General Universitario, Castellón, Spain.
Barger D; Univ. Bordeaux, ISPED, Centre INSERM U1219-Bordeaux Population Health, F-33000 Bordeaux, France.
Clifford GM; International Agency for Research on Cancer, Lyon, France.
Franceschi S; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Egger M; Institute of Social and Preventive Medicine, University of Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
Bohlius J; Institute of Social and Preventive Medicine, University of Bern, Switzerland.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Feb 01; Vol. 146 (3), pp. 601-609. Date of Electronic Publication: 2019 Jun 19.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Health Status Disparities*
HIV Infections/*complications
Uterine Cervical Neoplasms/*epidemiology
Adolescent ; Adult ; Age Factors ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Cross-Cultural Comparison ; Early Detection of Cancer ; Europe/epidemiology ; Female ; Follow-Up Studies ; HIV Infections/blood ; HIV Infections/drug therapy ; Humans ; Incidence ; Latin America/epidemiology ; Middle Aged ; North America/epidemiology ; Risk Factors ; South Africa/epidemiology ; Uterine Cervical Neoplasms/complications ; Uterine Cervical Neoplasms/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł :
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.
Autorzy :
Landy R; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA.
Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA.
Sasieni PD; Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, Guys Cancer Centre, Guys Hospital, King's College London, London, SE1 9RT, United Kingdom.
Cheung LC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA.
Katki HA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA.
Rydzak G; Information Management Services Inc., Calverton, MD, USA.
Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA.
Poitras NE; Regional Laboratory, Kaiser Permanente Northern California, Berkeley, CA, USA.
Lorey T; Regional Laboratory, Kaiser Permanente Northern California, Berkeley, CA, USA.
Kinney WK; Division of Gynaecologic Oncology, Kaiser Permanente Medical Care Program, Oakland, CA, USA.
Castle PE; Albert Einstein College of Medicine, Bronx, NY, USA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Feb 01; Vol. 146 (3), pp. 617-626. Date of Electronic Publication: 2019 Apr 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma in Situ/*epidemiology
Cervical Intraepithelial Neoplasia/*epidemiology
Papillomavirus Infections/*epidemiology
Precancerous Conditions/*epidemiology
Uterine Cervical Neoplasms/*prevention & control
Adenocarcinoma in Situ/diagnosis ; Adenocarcinoma in Situ/pathology ; California/epidemiology ; Cervical Intraepithelial Neoplasia/diagnosis ; Cervical Intraepithelial Neoplasia/pathology ; Cervix Uteri/pathology ; Early Detection of Cancer/standards ; Female ; Humans ; Mass Screening/standards ; Middle Aged ; Papillomaviridae/isolation & purification ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/virology ; Practice Guidelines as Topic ; Precancerous Conditions/diagnosis ; Precancerous Conditions/pathology ; Prospective Studies ; Risk Assessment/statistics & numerical data ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.
Autorzy :
Sadri Nahand J; Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Student Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Moghoofei M; Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Salmaninejad A; Drug Applied Research Center, Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran.; Department of Medical Genetics, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Bahmanpour Z; Department of Medical Genetics, Faculty of Medicine, Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Karimzadeh M; Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Nasiri M; Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mirzaei HR; Department of Medical Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Pourhanifeh MH; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Bokharaei-Salim F; Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mirzaei H; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran.
Hamblin MR; Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Jan 15; Vol. 146 (2), pp. 305-320. Date of Electronic Publication: 2019 Oct 31.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Exosomes/*immunology
Inflammation/*immunology
MicroRNAs/*metabolism
Papillomavirus Infections/*immunology
Uterine Cervical Neoplasms/*immunology
Female ; Gene Expression Regulation/immunology ; Host-Pathogen Interactions/genetics ; Host-Pathogen Interactions/immunology ; Humans ; Inflammation/pathology ; Inflammation/virology ; Papillomaviridae/immunology ; Papillomaviridae/pathogenicity ; Papillomavirus Infections/pathology ; Papillomavirus Infections/virology ; Risk Factors ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology ; Viral Proteins/immunology ; Viral Proteins/metabolism
Czasopismo naukowe
Tytuł :
Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
Autorzy :
Braun JA; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Herrmann AL; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Blase JI; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Frensemeier K; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Bulkescher J; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Scheffner M; Department of Biology, University of Konstanz, Konstanz, Germany.
Galy B; Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hoppe-Seyler K; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hoppe-Seyler F; Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Jan 15; Vol. 146 (2), pp. 461-474. Date of Electronic Publication: 2019 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Ciclopirox/*pharmacology
DNA-Binding Proteins/*antagonists & inhibitors
Oncogene Proteins, Viral/*antagonists & inhibitors
Papillomavirus E7 Proteins/*antagonists & inhibitors
Papillomavirus Infections/*drug therapy
Repressor Proteins/*antagonists & inhibitors
Uterine Cervical Neoplasms/*drug therapy
Antifungal Agents/pharmacology ; Antifungal Agents/therapeutic use ; Apoptosis/drug effects ; Cellular Senescence/drug effects ; Ciclopirox/therapeutic use ; DNA-Binding Proteins/metabolism ; Female ; HCT116 Cells ; HeLa Cells ; Humans ; Iron Chelating Agents/pharmacology ; Iron Chelating Agents/therapeutic use ; Oncogene Proteins, Viral/metabolism ; Papillomavirus E7 Proteins/metabolism ; Papillomavirus Infections/pathology ; Papillomavirus Infections/virology ; Repressor Proteins/metabolism ; Spheroids, Cellular ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
Tytuł :
Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
Autorzy :
Elfström KM; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Regional Cancer Center Stockholm Gotland, Stockholm, Sweden.
Sundström K; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Andersson S; Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden.
Bzhalava Z; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Carlsten Thor A; Regional Cancer Center Stockholm Gotland, Stockholm, Sweden.
Gzoul Z; Regional Cancer Center Stockholm Gotland, Stockholm, Sweden.
Öhman D; Regional Cancer Center Stockholm Gotland, Stockholm, Sweden.
Lamin H; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Eklund C; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Dillner J; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.; Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Törnberg S; Regional Cancer Center Stockholm Gotland, Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Dec 01; Vol. 145 (11), pp. 3033-3039. Date of Electronic Publication: 2019 May 10.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Early Detection of Cancer/*methods
Papillomavirus Infections/*diagnosis
Uterine Cervical Neoplasms/*diagnosis
Adult ; Female ; Humans ; Mass Screening/methods ; Middle Aged ; Papanicolaou Test/methods ; Papillomavirus Infections/epidemiology ; Self Care ; Sweden/epidemiology ; Telemedicine ; Uterine Cervical Neoplasms/enzymology ; Uterine Cervical Neoplasms/virology ; Vaginal Smears/methods ; Women's Health Services
Czasopismo naukowe
Tytuł :
Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancer.
Autorzy :
Tian J; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Geng Y; Department of Radiotherapy, Ansteel Group Hospital, Anshan, Liaoning, China.
Lv D; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Li P; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Cordova M; Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Liao Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Tian X; The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Zhang Q; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Zou K; The first affiliated hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhang Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Zhang X; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Li Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Zhang J; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Ma Z; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Shao Y; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Song L; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Owen GI; Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Li T; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Liu R; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Liu Q; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Zou L; The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zhang Z; The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
Li Z; Center of Genome and Personalized Medicine, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, Liaoning, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Nov 01; Vol. 145 (9), pp. 2547-2557. Date of Electronic Publication: 2019 Apr 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell-Free Nucleic Acids/*blood
Cell-Free Nucleic Acids/*genetics
Circulating Tumor DNA/*blood
Circulating Tumor DNA/*genetics
Uterine Cervical Neoplasms/*blood
Uterine Cervical Neoplasms/*genetics
Adult ; Aged ; Alleles ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; Chemoradiotherapy/methods ; DNA, Neoplasm/blood ; DNA, Neoplasm/genetics ; Female ; Genome/genetics ; Genomics/methods ; Humans ; Middle Aged ; Mutation/genetics ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
Autorzy :
Orumaa M; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Leinonen MK; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Campbell S; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Møller B; Department of Registration, Cancer Registry of Norway, Oslo, Norway.
Myklebust TÅ; Department of Registration, Cancer Registry of Norway, Oslo, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.
Nygård M; Department of Research, Cancer Registry of Norway, Oslo, Norway.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Nov 15; Vol. 145 (10), pp. 2629-2638. Date of Electronic Publication: 2019 Mar 04.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma in Situ/*epidemiology
Cervical Intraepithelial Neoplasia/*epidemiology
Mass Screening/*statistics & numerical data
Precancerous Conditions/*epidemiology
Uterine Cervical Neoplasms/*prevention & control
Adenocarcinoma in Situ/diagnosis ; Adenocarcinoma in Situ/virology ; Adult ; Aged ; Antiviral Agents/therapeutic use ; Cervical Intraepithelial Neoplasia/diagnosis ; Cervical Intraepithelial Neoplasia/virology ; Cervix Uteri/pathology ; Cervix Uteri/virology ; Female ; Humans ; Incidence ; Mass Screening/methods ; Middle Aged ; Norway/epidemiology ; Papillomaviridae/isolation & purification ; Papillomaviridae/pathogenicity ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/therapy ; Papillomavirus Infections/virology ; Precancerous Conditions/diagnosis ; Precancerous Conditions/virology ; Registries/statistics & numerical data ; Uterine Cervical Neoplasms/pathology ; Uterine Cervical Neoplasms/virology ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination.
Autorzy :
Kong Y; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.; Department of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Wang Z; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.
Huang M; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.
Zhou Z; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.
Li Y; State Key Laboratory of Molecular Oncology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Miao H; Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Wan X; Department of Dermatology, Jingmen No.1 people's Hospital, Jingmen, Hubei, China.
Huang J; Department of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Mao X; Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Chen C; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences and Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.; Department of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Sep 01; Vol. 145 (5), pp. 1371-1381. Date of Electronic Publication: 2019 Mar 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms/*enzymology
Caspase 8/*metabolism
Cullin Proteins/*metabolism
Uterine Cervical Neoplasms/*enzymology
Animals ; Apoptosis/drug effects ; Apoptosis/physiology ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Survival/immunology ; Cullin Proteins/genetics ; Female ; HEK293 Cells ; HeLa Cells ; Heterografts ; Humans ; MCF-7 Cells ; Mice ; Recombinant Proteins/pharmacology ; TNF-Related Apoptosis-Inducing Ligand/pharmacology ; Ubiquitination ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/genetics ; Uterine Cervical Neoplasms/pathology
Czasopismo naukowe
Tytuł :
REBACIN® as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection.
Autorzy :
Yang Y; Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China.
Meng YL; Department of Obstetrics and Gynaecology, Tianjin Medical University General Hospital, Tianjin, China.; Department of Obstetrics and Gynaecology, Tianjin Port Hospital, Tianjin, China.
Duan SM; National Institute for Viral Disease Control and Prevention, Beijing, China.
Zhan SB; National Institute for Viral Disease Control and Prevention, Beijing, China.
Guan RL; Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China.
Yue TF; Department of Obstetrics and Gynaecology, Tianjin Medical University General Hospital, Tianjin, China.
Kong LH; Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China.
Zhou L; National Institute for Viral Disease Control and Prevention, Beijing, China.
Deng LH; Division of Medical Biology, Key Laboratory of Protein Engineering and Drug Development of Hainan, Haikou, Hainan, China.
Huang C; Division of Medical Biology, Key Laboratory of Protein Engineering and Drug Development of Hainan, Haikou, Hainan, China.
Wang S; Division of Medical Biology, Key Laboratory of Protein Engineering and Drug Development of Hainan, Haikou, Hainan, China.
Wang GY; Division of Medical Biology, Key Laboratory of Protein Engineering and Drug Development of Hainan, Haikou, Hainan, China.
Wu DF; SR Life Sciences Institute, Clarksburg, MD.
Zhang CF; SR Life Sciences Institute, Clarksburg, MD.
Chen F; Department of Obstetrics and Gynaecology, Peking Union Medical College Hospital, Beijing, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Nov 15; Vol. 145 (10), pp. 2712-2719. Date of Electronic Publication: 2019 Apr 29.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Biological Products/*therapeutic use
Papillomavirus Infections/*drug therapy
Uterine Cervical Neoplasms/*prevention & control
Adult ; Animals ; Antiviral Agents/pharmacology ; Biological Products/pharmacology ; Disease Models, Animal ; Female ; HeLa Cells ; Human papillomavirus 16/drug effects ; Human papillomavirus 16/pathogenicity ; Humans ; Mice ; Middle Aged ; Oncogene Proteins, Viral/antagonists & inhibitors ; Papillomavirus E7 Proteins/antagonists & inhibitors ; Papillomavirus Infections/virology ; Repressor Proteins/antagonists & inhibitors ; Treatment Outcome ; Uterine Cervical Neoplasms/virology ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Performance of an HPV 16/18 E6 oncoprotein test for detection of cervical precancer and cancer.
Autorzy :
Ferrera A; Escuela de Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Valladares W; Escuela de Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Cabrera Y; Escuela de Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
de la Luz Hernandez M; Prevention and Implementation Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Darragh T; Department of Pathology, UCSF Mt. Zion Medical Center, San Francisco, CA.
Baena A; Prevention and Implementation Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Almonte M; Prevention and Implementation Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Herrero R; Prevention and Implementation Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Oct 15; Vol. 145 (8), pp. 2042-2050. Date of Electronic Publication: 2019 Feb 19.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Cervical Intraepithelial Neoplasia/*diagnosis
DNA-Binding Proteins/*genetics
Early Detection of Cancer/*methods
Oncogene Proteins, Viral/*genetics
Papillomavirus Infections/*diagnosis
Repressor Proteins/*genetics
Uterine Cervical Neoplasms/*diagnosis
Adult ; Cervical Intraepithelial Neoplasia/virology ; DNA, Viral/genetics ; Female ; Genotype ; Humans ; Middle Aged ; Papillomaviridae/classification ; Papillomaviridae/genetics ; Papillomavirus Infections/virology ; Polymerase Chain Reaction/methods ; Precancerous Conditions/diagnosis ; Precancerous Conditions/virology ; Sensitivity and Specificity ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe
Tytuł :
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort.
Autorzy :
Bonde J; Molecular Pathology Laboratory, Department of Pathology, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark.
Bottari F; Laboratory Medicine Division, European Institute of Oncology, Milan, Italy.
Parvu V; Becton Dickinson and Company, Sparks, MD, USA.
Pedersen H; Molecular Pathology Laboratory, Department of Pathology, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark.
Yanson K; Becton Dickinson and Company, Sparks, MD, USA.
Iacobone AD; Preventive Gynecology Unit, European Institute of Oncology, Milan, Italy.
Kodsi S; Becton Dickinson and Company, Sparks, MD, USA.
Landoni F; Department of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.
Vaughan L; Becton Dickinson and Company, Sparks, MD, USA.
Ejegod DM; Molecular Pathology Laboratory, Department of Pathology, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark.
Sandri MT; Laboratorio Analisi Cliniche, Humanitas Research Hospital, Milan, Italy.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Aug 15; Vol. 145 (4), pp. 1033-1041. Date of Electronic Publication: 2019 Apr 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Papillomaviridae/*genetics
Papillomavirus Infections/*complications
Uterine Cervical Neoplasms/*etiology
Uterine Cervical Neoplasms/*virology
Adolescent ; Adult ; Aged ; Bayes Theorem ; Cohort Studies ; Early Detection of Cancer/methods ; Europe ; Female ; Genotype ; Humans ; Mass Screening ; Middle Aged ; Papillomavirus Infections/diagnosis ; Papillomavirus Infections/virology ; Risk ; Uterine Cervical Neoplasms/diagnosis ; Young Adult
Czasopismo naukowe
Tytuł :
Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing.
Autorzy :
Andreassen T; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.; Institute of Health and Society, University of Oslo, Oslo, Norway.
Hansen BT; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.
Engesaeter B; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.
Hashim D; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.; Department of Haematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
Støer NC; Oslo University Hospital, Norwegian National Advisory Unit on Women's Health, Oslo, Norway.
Tropé A; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.
Moen K; Institute of Health and Society, University of Oslo, Oslo, Norway.
Ursin G; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.; University of Southern California, Department of Preventive Medicine, Los Angeles, CA.
Weiderpass E; Cancer Registry of Norway, Institute of PopulationBased Cancer Research, Oslo, Norway.; Folkhälsan Research Centre, Genetic Epidemiology Group, and Faculty of Medicine, Helsinki University, Helsinki, Finland.; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Jul 01; Vol. 145 (1), pp. 29-39. Date of Electronic Publication: 2019 Jan 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Early Detection of Cancer/*psychology
Papillomaviridae/*isolation & purification
Papillomavirus Infections/*psychology
Uterine Cervical Neoplasms/*psychology
Adult ; Aged ; Anxiety/etiology ; Depression/etiology ; Early Detection of Cancer/methods ; Female ; Humans ; Middle Aged ; Norway/epidemiology ; Papillomavirus Infections/epidemiology ; Papillomavirus Infections/virology ; Registries ; Uterine Cervical Neoplasms/epidemiology ; Uterine Cervical Neoplasms/virology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies